Production (Stage)
International Stem Cell Corporation
ISCO
$0.1201
-$0.0466-27.95%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.29% | -59.54% | -293.71% | -595.65% | 12.64% |
| Total Depreciation and Amortization | 10.42% | 6.19% | 1.01% | -5.83% | -9.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.05% | -0.92% | 22.78% | 32.75% | 35.34% |
| Change in Net Operating Assets | -36.30% | -28,066.67% | 52.30% | -101.79% | -1,783.33% |
| Cash from Operations | -16.73% | -98.60% | -70.72% | -93.90% | -8.93% |
| Capital Expenditure | -123.29% | -107.50% | -106.25% | -115.15% | -356.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -66.67% | -100.00% | 57.14% | 60.00% |
| Cash from Investing | -116.88% | -106.02% | -106.02% | -98.63% | -196.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -85.10% | -142.32% | -116.10% | -111.56% | -18.72% |